1841P Predicting the onset of immune-related adverse events (irAEs) in immune checkpoint inhibitor (ICI) therapies using a machine learning (ML) model trained with electronic patient-reported outcomes (ePROs) and lab measurements.

Authors :: Iivanainen, S.M.E.
Ekstrom, J.
Kataja, V.
Virtanen, H.
Koivunen, J.
Source :: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1057-S1057. 1p.
Publication Year :: 2020

Subjects :: *DRUG side effects
*IMMUNE checkpoint inhibitors
*MACHINE learning

Full Text Access

Tools